IMPACT-AD 2023 Request for Applications

With support from the National Institute on Aging and the Alzheimer’s Association, a program to train the next generation of clinical trialists in Alzheimer’s Disease and Related Dementias (ADRD) will be offered August 27- September 1, 2023, in San Diego, CA.

The Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (IMPACT-AD) provides a unique, comprehensive, and active learning experience in AD/ADRD trials by leveraging the full infrastructure and expertise of the Alzheimer’s Clinical Trials Consortium (ACTC).

IMPACT-AD is open to a diverse range of clinicians, scientists and research professionals including those with and without previous
experience in AD/ADRD. IMPACT-AD provides a modern and robust training on AD/ADRD clinical trials by experienced and renowned clinical trialists with a focus on team science. Training topics include ADRD trial design, biostatistics, participant recruitment and retention, trial ethics, outcome measures (clinical, imaging, digital and biofluid biomarkers), study management and more.

IMPACT-AD 2023 is now accepting applications. Individuals with broad-ranging experience and expertise in AD/ADRD and/or clinical trials with an interest in a career in AD/ADRD clinical trials are encouraged to apply.

Participation is competitive and open to individuals with a full-time position at their respective Institutions within the United States. IMPACT-AD will cover all travel costs for accepted trainees.

Two unique in-person tracks will be offered as part of IMPACT-AD 2023. Tracks will commence simultaneously and overlap. Applicants are permitted to apply to only one track per application cycle.

• Professionals Track - This track seeks applications from individuals with at least 2 years of experience in AD/ADRD research and/or clinical trials (in a broad variety of roles including, but not limited to clinicians, study coordinators, statisticians, psychometricians, and other study professionals) who wish to further their knowledge and advance their careers in AD/ADRD clinical trials (3.5 days).
• Fellowship Track - This track seeks applications from individuals seeking to serve as Principal Investigators in AD/ADRD trials now or in the future and offers mentored training in protocol development. Applications are open to individuals in their fellowship or postdoctoral training, faculty members or equivalent positions (5.5 days)

Submission requirements:

• NIH Biosketch (both tracks)
• A career statement (both tracks)
• Institutional letter of support (both tracks)
• Brief trial synopsis (Fellowship track only)

All materials must be submitted electronically through ProposalCentral by 5:00PM PST April 30, 2023.

Attendees will be selected after an expert peer review of application materials. Priority will be given to applicants whose career statement, Institutional letter of support, and (if applicable) the quality of the proposed research synopsis (significance, innovation, and approach), demonstrate a commitment to AD/ADRD clinical trials research.

More information, including submission templates and instructions, an informational webinar and a FAQ, is available at the IMPACT-AD website (www.impact-ad.org). For other questions, please contact the IMPACT-AD Program Administrator, Ms. Maggie Mastrolorenzo, at mastrolo@usc.edu.